EGFR and non-small cell lung carcinoma: Notably, EGFR- and KRAS-mutant NSCLC cases typically exhibit a reduced proportion of TILs and corresponding low ICR expression, indicating a deficiency in immune engagement rather than a fully functional T cell population [76].